Nathan Boersen
About Nathan Boersen
Nathan Boersen is a Senior Principal Scientist at Bristol Myers Squibb, with a background in pharmaceutical development and chemical engineering.
Current Role at Bristol Myers Squibb
Nathan Boersen is a Senior Principal Scientist at Bristol Myers Squibb. In this capacity, he has been instrumental in advancing scientific projects and has a key role in integrating cross-functional knowledge management. His responsibilities include overseeing contract work with Contract Manufacturing Organizations (CMOs) and preparing timelines, budgets, and patent applications for various pharmaceutical developments.
Career at Celgene
From 2009 to 2019, Nathan Boersen worked as a Senior Scientist at Celgene in Summit, NJ. During this decade-long tenure, he made significant contributions to the company's pharmaceutical development programs. His work included enhancing data capture and sharing within the department through the integration of an electronic notebook, where he led the design layout, beta testing, training, and rollout.
Educational Background
Nathan Boersen achieved his Ph.D. in Industrial and Physical Pharmacy from Purdue University, where he studied from 2004 to 2009. Earlier, he completed a B.S. in Chemical Engineering from Michigan State University, studying from 1998 to 2003. His educational foundation laid the groundwork for his extensive expertise in the pharmaceutical industry.
Early Career and Internships
Nathan Boersen has held various positions early in his career. He worked as a Graduate Student at Purdue University from 2004 to 2009. He also served as a Post Undergraduate Intern at GlaxoSmithKline in 2004 for 3 months and as a Summer/Fall Co-op at Pharmacia Corporation in 2001 for 7 months. These roles provided him with valuable industry experience and insights.
Key Projects and Initiatives
Nathan Boersen co-established the Accelerated Stability Assessment Program (ASAP) within Pharmaceutical Development, effectively reducing the time needed to assess the stability of drug substances and products. He also led efforts to understand the mechanism of disproportionation and dissolution slow down, which contributed to the development of a new formulation. His initiative to increase data capture and sharing within his department has been pivotal, where he was responsible for the design, beta testing, and rollout of electronic notebooks.